These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18606056)

  • 1. [A Kras-specific function in cancer initiation].
    Quinlan MP; Settleman J
    Ai Zheng; 2008 Jul; 27(7):673-4. PubMed ID: 18606056
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-mediated regulation of KRAS in cancer.
    Kim M; Slack FJ
    J Hematol Oncol; 2014 Nov; 7():84. PubMed ID: 25433809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quo vadis, Kras?
    Schneider G; Saur D
    Oncotarget; 2013 Sep; 4(9):1336-7. PubMed ID: 23978899
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene of the month: KRAS.
    Chetty R; Govender D
    J Clin Pathol; 2013 Jul; 66(7):548-50. PubMed ID: 23626007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Climbing RAS, the everest of oncogenes.
    Russo M; Di Nicolantonio F; Bardelli A
    Cancer Discov; 2014 Jan; 4(1):19-21. PubMed ID: 24402942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cell line model for cancer-associated KRAS noncoding SNP.
    Lauring J
    Hum Mutat; 2014 Feb; 35(2):v. PubMed ID: 24415639
    [No Abstract]   [Full Text] [Related]  

  • 7. KRAS mutations in historical tumour specimens of the Viennese Museum of pathological anatomy.
    Sedivy R; Kalipciyan M; Patzak B; Mader RM
    Histopathology; 2011 Apr; 58(5):792-6. PubMed ID: 21457164
    [No Abstract]   [Full Text] [Related]  

  • 8. KRAS mutation detection: a new look at an old gene.
    Lefferts JA; Tsongalis GJ; Suriawinata AA; Funkhouser WK; Ladanyi M; Nowak JA; Pipas JM
    Clin Chem; 2010 May; 56(5):698-701. PubMed ID: 20207769
    [No Abstract]   [Full Text] [Related]  

  • 9. Explaining the preponderance of Kras mutations in human cancer: An isoform-specific function in stem cell expansion.
    Quinlan MP; Settleman J
    Cell Cycle; 2008 May; 7(10):1332-5. PubMed ID: 18418066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS 3'-UTR variants and stratification of breast-cancer risk.
    Kumar MS; Swanton C
    Lancet Oncol; 2011 Apr; 12(4):318-9. PubMed ID: 21435949
    [No Abstract]   [Full Text] [Related]  

  • 11. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.
    Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
    Oncol Rep; 2007 Sep; 18(3):623-8. PubMed ID: 17671710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GI-4000 in KRAS mutant cancers.
    Shahda S; O'Neil B
    Expert Opin Investig Drugs; 2014 Feb; 23(2):273-8. PubMed ID: 24372276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
    Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
    J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS mutations: an old oncogene becomes a new predictive biomarker.
    Riely GJ; Ladanyi M
    J Mol Diagn; 2008 Nov; 10(6):493-5. PubMed ID: 18832458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
    Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
    Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
    Garassino MC; Farina G; Rossi A; Martelli O; Torri V
    J Clin Oncol; 2008 May; 26(15):2600; author reply 2601-2. PubMed ID: 18487581
    [No Abstract]   [Full Text] [Related]  

  • 17. Applying synthetic lethality for the selective targeting of cancer.
    McLornan DP; List A; Mufti GJ
    N Engl J Med; 2014 Oct; 371(18):1725-35. PubMed ID: 25354106
    [No Abstract]   [Full Text] [Related]  

  • 18. T-Cell Transfer Therapy Targeting Mutant KRAS.
    Rech AJ; Vonderheide RH
    N Engl J Med; 2017 Feb; 376(7):e11. PubMed ID: 28207208
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.
    Xodo L; Paramasivam M; Membrino A; Cogoi S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):159-60. PubMed ID: 18776302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a patient with atypical MUTYH-associated polyposis through detection of the KRAS c.34G>T mutation in liver metastasis.
    Buisine MP; Cattan S; Wacrenier A; Leclerc J; Lejeune S
    J Clin Oncol; 2013 Mar; 31(9):e125-7. PubMed ID: 23341527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.